Microaneurysms cause refractory macular edema in branch retinal vein occlusion
Intravitreal anti-vascular endothelial growth factor (VEGF) agents can treat macular edema (ME) in branch retinal vein occlusion (BRVO). However, refractory ME, the mechanism of which is not well elucidated, occurs frequently. Sixty-six eyes with ME secondary to BRVO were enrolled in this retrospect...
Main Authors: | Tomiyasu, Taneto, Hirano, Yoshio, Yoshida, Munenori, Suzuki, Norihiro, Nishiyama, Takeshi, Uemura, Akiyoshi, Yasukawa, Tsutomu, Ogura, Yuichiro |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937381/ |
Similar Items
-
Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
by: Kawamura M, et al.
Published: (2018-08-01) -
Preoperative optical coherence tomography visualization of epiretinal membranes enhances surgical strategies
by: Suzuki, Norihiro, et al.
Published: (2016) -
Refractory Diabetic Macular Edema
by: Bainbridge, James
Published: (2010) -
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
by: Udaondo, Patricia, et al.
Published: (2011) -
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
by: Azad, Rajvardhan, et al.
Published: (2012)